A study of more than 33,000 outpatient male veterans suggests that a duration of antimicrobial treatment of more than 7 days for a urinary tract infection (UTI) does not reduce the risk of early or late recurrence compared to a shorter duration (7 days or less) of treatment.
An orally bioavailable tyrosine kinase inhibitor demonstrated dramatic and rapid effects on advanced prostate cancer, according to researchers from the University of Michigan Comprehensive Cancer Center, Ann Arbor.
Image-guided targeted biopsy can be used to diagnose prostate cancer, potentially offering a more accurate approach than traditional blind biopsy, according to a recently published study.
Urinary continence and sexual function scores are similar up to 2 years after robot-assisted and open radical prostatectomy, especially when the procedures are performed by skilled, high-volume surgeons, new research shows.
Ajay Singla, MD, has joined The University of Toledo Medical Center, Toledo, OH, and separately, David M. Barrett, MD, has been elected to the board of directors of ProUroCare Medical Inc. in Minneapolis.
Joseph E. Murray, MD, a surgeon and Nobel Prize winner who conducted the world?s first successful organ transplant, died Nov. 26 at age 93.
About half of physicians treating patients with advanced renal cell carcinoma (RCC) believe that working with a comprehensive care team is extremely beneficial in helping to effectively manage adverse events associated with newer targeted therapies, according to a recently released survey.
Isolated cryptorchidism is linked to a higher likelihood of testicular cancer development, say researchers from the United Kingdom.
AVEO Oncology and Astellas Pharma Inc. have announced that the FDA has accepted for filing the new drug application (NDA) for tivozanib with the proposed indication for the treatment of patients with advanced renal cell carcinoma.
In this interview, Laurence Klotz, MD, discusses his group's active surveillance protocol for men with favorable-risk prostate cancer, which men are candidates, how they are monitored, and triggers for active treatment.
Good long-term cancer-specific outcome is possible in well-selected prostate cancer patients found to have lymph node-positive disease at radical prostatectomy, findings from analyses based on 30 years of experience at a single institution demonstrate.
If patients are surprised by a complication and/or adverse outcome, a lawsuit is more likely than if the risks/benefits are explained and create realistic expectations of outcomes for that particular patient and are documented in the medical record.
Generally speaking, for Stage 2 of meaningful use, the bar has been raised; the threshold for measures is higher than it was in Stage 1.
The re-election of President Obama and the strengthened numbers of Democrats in both the House and Senate mean that key provisions of the Affordable Care Act are likely to be implemented over the next 2 years.
A group of researchers at Cornell University's Weill Medical College, New York is using magnetic resonance imaging technology at 7 Tesla to obtain prostate tissue images whose resolution rivals that seen with hematoxylin and eosin (H&E) stains.
Finding ways to retain the superstars who make your urology practice shine-without risking your profitability-is critical to your practice's long-term success.
In experienced hands, holmium laser enucleation of the prostate in men with BPH with glands 200 grams or greater yields outcomes similar to those of simple open prostatectomy with much less morbidity, according to a retrospective review at a single center.
There may be just one predictor of urinary incontinence after pelvic organ prolapse repair-urinary incontinence.
In this article, we cover a few issues gleaned from the 1,362-page final rule that could have an effect on your urology practice.
Heading into 2013, urologists remain deeply concerned about declining reimbursement for their services, increasing government regulations, and implementation of the Affordable Care Act, according to the 2012 Urology Times State of the Specialty survey.
A study investigating trends in ambulatory surgery for stress urinary incontinence shows a significant fourfold increase in the annual rate of sling procedures performed over a contemporary 9-year period, and yet, submucosal injection therapy appears to be maintaining a niche for the treatment of certain patients, report researchers from the University of Michigan, Ann Arbor.
The key to determining what to invest in should be based primarily on the needs, temperament, and available resources of each individual or family.
Men taking statin drugs had a modest reduction in prostate growth in a new analysis of a 4-year, large, randomized trial of the dual 5-alpha-reductase inhibitor dutasteride (Avodart) versus placebo for risk reduction of prostate cancer among high-risk men.
Photoselective vaporization of the prostate using the GreenLight XPS 180W laser system (American Medical Systems, Minnetonka, MN) is associated with reduced operative time and fiber usage compared with the GreenLight HPS 120W while resulting in lower PSA levels 6 months post-procedure.
Men with low-risk prostate cancer have good mortality prospects even when they experience early biochemical recurrence following radical prostatectomy, according to the results of an Australian study.
The autonomy of a growing number of employed physicians should be respected, and patient care should come before the financial interests of employers, according to principles on physician employment adopted at the recent American Medical Association interim meeting in Honolulu.
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent report.
For nearly half of U.S. urologists, malpractice insurance premiums in 2011 stayed the same as 2010 levels, according to a recent survey.
Stenting a pelvic artery may be a treatment option for erectile dysfunction (ED) in men who don't respond to drug therapy, according to a recent study.